Results 171 to 180 of about 123,627 (298)

Dynamic and Objective Quantification of Facial Nerve Palsy Using Smartphone‐Based 3D Facial Geometry

open access: yesThe Laryngoscope, EarlyView.
This prospective study evaluated smartphone‐captured high‐resolution 3D facial geometry in 99 patients with unilateral facial nerve palsy across 207 visits and 12 healthy volunteers. Dynamic motion features combined with machine learning accurately estimated signed continuous House–Brackmann severity and identified clinically significant palsy ...
Koki Hasebe   +9 more
wiley   +1 more source

Novel Injectable Supports Long‐Term Recurrent Laryngeal Nerve and Partial Peripheral Nerve Repair

open access: yesThe Laryngoscope, EarlyView.
Following recurrent laryngeal nerve transection in C57BL/6 mice, intramuscular Agrin, neuregulin‐1, and acetylcholine treatment of the thyroarytenoid muscle supported functional reinnervation and preservation of neuromuscular structure at 84 days.
Aditya Bhatt   +10 more
wiley   +1 more source

Invention of the Flexible Fiberoptic Nasopharyngolaryngoscope: Perspectives From the East

open access: yesThe Laryngoscope, EarlyView.
The fiberoptic nasopharyngolaryngoscope was developed in 1967 by Drs. Masayuki Sawashima, Hajime Hirose, and Osamu Fujimura at the University of Tokyo's Research Institute of Logopedics and Phoniatrics (RILP), building on Dr. Shigeto Ikeda's 1962 fiberoptic bronchoscope during Japan's postwar surge in technological innovation.
Carolyn J. Khoury   +7 more
wiley   +1 more source

Myofibrillar Myopathy with Pyramidal Signs Mimicking Amyotrophic Lateral Sclerosis. [PDF]

open access: yesAnn Indian Acad Neurol
Mirg S   +7 more
europepmc   +1 more source

Real‐World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9‐Year Nationwide Analysis in France

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau   +3 more
wiley   +1 more source

Characterisation of Pelvic Floor Muscle Activation in Adults With Intellectual Disability Using Surface Electromyography: A Comparative Cross-Sectional Study. [PDF]

open access: yesJ Appl Res Intellect Disabil
López-Lezcano A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy